merck glp 1 Enters into Exclusive Global License Agreement with Hansoh Pharma for Investigational Oral GLP-1 Receptor Agonist Merck pays $112M upfront for

Yes, and were also fully operated by a Canada-based team Domestic Fulfillment: No duties, import delays, or currency exchange fees Location: Ontario, Canada Do you provide medical advice or usage instructions

Ready to make 2026 your healthiest year yet

What the Research Shows BPC-157 has accumulated substantial scientific evidence supporting its healing properties, though nearly all research involves animal models rather than controlled human trials

Tissue repair is essential for breaking the cycle where damaged tissues become more reactive, which triggers more inflammation, which causes more damage

This will depend on whether youre taking them for an approved use or not